| Valproic acid | Approved Investigational | AEBP2 | 121536 |
downregulated | Valproic Acid results in decreased expression of AEBP2 mRNA | 12p12.3 | |
| Valproic acid | Approved Investigational | AES | 166 |
downregulated | Valproic Acid results in decreased expression of AES mRNA | 19p13.3 | |
| Valproic acid | Approved Investigational | AFAP1 | 60312 |
upregulated | Valproic Acid results in increased expression of AFAP1 mRNA | 4p16.1 | |
| Valproic acid | Approved Investigational | AFAP1L1 | 134265 |
upregulated | Valproic Acid results in increased expression of AFAP1L1 mRNA | 5q32 | |
| Valproic acid | Approved Investigational | AFAP1L2 | 84632 |
upregulated | Valproic Acid results in increased expression of AFAP1L2 mRNA | 10q25.3 | |
| Valproic acid | Approved Investigational | AFDN-AS1 | 653483 |
downregulated | Valproic Acid results in decreased expression of AFDN-AS1 mRNA | 6q27 | |
| Valproic acid | Approved Investigational | AFF2 | 2334 |
upregulated | Valproic Acid results in increased expression of AFF2 mRNA | Xq28 | |
| Valproic acid | Approved Investigational | AFF3 | 3899 |
upregulated | Valproic Acid results in increased expression of AFF3 mRNA | 2q11.2 | |
| Valproic acid | Approved Investigational | AFF4 | 27125 |
downregulated | Valproic Acid results in decreased expression of AFF4 mRNA | 5q31.1 | |
| Valproic acid | Approved Investigational | AFG3L1P | 172 |
downregulated | Valproic Acid results in decreased expression of AFG3L1P mRNA | 16q24.3 | |
| Valproic acid | Approved Investigational | AFP | 174 |
downregulated | Valproic Acid results in decreased expression of AFP mRNA | 4q13.3 | |
| Valproic acid | Approved Investigational | AFP | 174 |
upregulated | Valproic Acid results in increased expression of AFP mRNA | 4q13.3 | |
| Valproic acid | Approved Investigational | AGA | 175 |
upregulated | Valproic Acid results in increased expression of AGA mRNA | 4q34.3 | |
| Valproic acid | Approved Investigational | AGAP1 | 116987 |
upregulated | Valproic Acid results in increased expression of AGAP1 mRNA | 2q37.2 | |
| Valproic acid | Approved Investigational | AGAP4 | 119016 |
downregulated | Valproic Acid results in decreased expression of AGAP4 mRNA | 10q11.22 | |
| Valproic acid | Approved Investigational | AGBL1 | 123624 |
downregulated | Valproic Acid results in decreased expression of AGBL1 mRNA | 15q25.3 | |
| Valproic acid | Approved Investigational | AGBL2 | 79841 |
downregulated | Valproic Acid results in decreased expression of AGBL2 mRNA | 11p11.2 | |
| Valproic acid | Approved Investigational | AGBL3 | 340351 |
downregulated | Valproic Acid results in decreased expression of AGBL3 mRNA | 7q33 | |
| Valproic acid | Approved Investigational | AGBL5 | 60509 |
upregulated | Valproic Acid results in increased expression of AGBL5 mRNA | 2p23.3 | |
| Valproic acid | Approved Investigational | AGFG1 | 3267 |
upregulated | Valproic Acid results in increased expression of AGFG1 mRNA | 2q36.3 | |
| Valproic acid | Approved Investigational | AGO1 | 26523 |
downregulated | Valproic Acid results in decreased expression of AGO1 mRNA | 1p34.3 | |
| Valproic acid | Approved Investigational | AGO2 | 27161 |
downregulated | Valproic Acid results in decreased expression of AGO2 mRNA | 8q24.3 | |
| Valproic acid | Approved Investigational | AGO4 | 192670 |
downregulated | Valproic Acid results in decreased expression of AGO4 mRNA | 1p34.3 | |
| Valproic acid | Approved Investigational | AGPAT3 | 56894 |
upregulated | Valproic Acid results in increased expression of AGPAT3 mRNA | 21q22.3 | |
| Valproic acid | Approved Investigational | AGPAT4 | 56895 |
downregulated | Valproic Acid results in decreased expression of AGPAT4 mRNA | 6q26 | |